Showing 2762 results
- Pulse Update /
- Story /
We're striving to help more people with chronic spontaneous urticaria—a skin condition marked by hives and distressful itching—return to their daily lives.
- Media Release /Continuous Kesimpta® (ofatumumab) treatment maintained profound suppression of MRI lesion activity and resulted in an increase in the number of patients with relapsing forms of multiple sclerosis (…
- Media Release /Sandoz AG to remain based in Basel, Switzerland following proposed spin-off from Novartis Announcement of planned city-center HQ marks important milestone as Sandoz prepares to become independent…
- Story /
People with breast cancer need better medicines that help reduce the risk and anxiety of it returning.
- Featured News /Annual meeting highlights progress on the company’s transformation and growth strategy.
Pagination
- ‹ Previous page
- 1
- …
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- …
- 277
- › Next page